Ming-Zhen Zhang, male, PI, vice director of the Institute of Medical Engineering, Institute of Translational Medicine, Xi'an Jiaotong University. Graduated from the Department of Biochemistry and Molecular Biology in Huazhong University of Science and Technology, majoring in Biochemistry and Molecular Biology, with a Ph.D. degree; Postdoctoral and Assistant Professor at Georgia State University, USA; in 2018, he joined the School of Basic Medicine, Xi'an Jiaotong University. Mainly engaged in the research of precision diagnosis and treatment of colitis and colon cancer, including: 1. Design of novel nano-based drug delivery system; 2. Construction of integrated diagnosis and treatment nano-probe; 3. Research and development of marker detection and sensor technology; 4. Intestinal microflora analysis. He has published more than 50 academic papers in related fields, 1 high-cited paper by ESI, more than 1,500 citations, H index 21, and 4 invention patents. Hosted/participated in more than 10 projects including the National Natural Science Foundation of China, the CCFA Foundation of the United States, the National Key Research and Development Program of the Ministry of Science and Technology, the Natural Science Foundation of Shaanxi Province, and the Open Fund of the Key Laboratory of Gastrointestinal Tumor Diagnosis and Treatment of the National Health Commission. Talent programs such as the "Young Distinguished Talents Support Program" of universities, the "Young Top Talents Program" of Xi'an Jiaotong University, and the "National Reserve Talents Support Program" of the Medical Department of Xi'an Jiaotong University. He has been invited as a reviewer for authoritative Journals such as ACS Nano, Theranostics, Advanced Functional Materials, etc. He is currently a council member of the Shaanxi Nanotechnology Association, a member of the American Gastroenterology Association (AGA), the Chinese Society of Biomaterials, and the Chinese Society of Medical Engineering.   Research 1： With inflammatory bowel disease (IBD) and colon cancer as research targets, focusing on disease diagnosis, treatment and pathogenic molecular mechanisms as follows: Design of novel nano-based drug delivery system. Construction of an integrated diagnosis and treatment nanoprobe system. Research and development of biomarker detection and sensing technology. Intestinal microflora analysis. Research 2： Research on ophthalmic biomaterials and pharmaceutical engineering. Including research contents such as ophthalmic drug carriers, nano biomaterials, nano biosensing and imaging.